Fonterra FY26 Results: $9.69 Milk Price, $3.4bn Profit
Fonterra has unveiled its annual results for the 2026 financial year, posting $27 billion in revenue and close to $20 billion returned to New Zealand farmer owners and unit holders.
Fonterra has recently doubled its capacity to produce lactoferrin, a high-value ingredient that requires 10,000 litres of milk to produce one kilogram.
The new $11 million upgrade of the lactoferrin plant at the co-op's Hautapu site is now running at full volume, helping to meet growing worldwide demand for the product known as 'pink gold'.
Lactoferrin is a naturally occurring iron-binding protein found in milk and is in high demand, particularly in Asia, for a wide range of nutritional applications from infant formula through to health foods and yoghurts.
Fonterra managing director global operations Robert Spurway says, although the volumes of lactoferrin the co-op exports seem small, compared to many other dairy ingredients, a little goes a long way.
"While we're seeing strong growth in demand for lactoferrin across a number of our key markets, the fact that we measure growth for this product in kilograms rather than in tonnes gives an idea as to the potency and value of lactoferrin.
"It really is the 'icing on the cake' for Fonterra, as it can be extracted out of skimmed milk or whey, without impacting the use of that milk in other dairy products."
Extracting this specialised protein from milk is something very few dairy manufacturers can do, due to the investment needed in both capital and research and development, says Spurway.
"Our ability to create value through the production of high quality lactoferrin is largely down to the work of our team at the Fonterra Research and Development Centre. For more than a decade they have been honing our processes and helping to improve our cost and speed of production, as well as the overall quality of the end product."
Fonterra chief science and technology officer Dr Jeremy Hill says growing demand for lactoferrin in many Asian countries is due to research showing the diverse biological functions of the protein.
"Lactoferrin is present in human milk in high proportions, and breast-fed infants will consume up to three grams a day during their first week of life. This abundance of lactoferrin in human milk is considered to be an indication of its importance in infant nutrition," says Hill.
"Because of this, our customers have invested in extensive research and trials on the benefits of lactoferrin particularly to the immune system, given its strong anti-microbial and anti-inflammatory properties."
Federated Farmers says it welcomes Labour's commitment to reviewing the Sharemilking Agreements Act, calling on other major parties to do the same.
For Canterbury dairy farmers Sian Meijer and Rick Wobben, wearable technology has become one of their most valuable on-farm tools - helping manage 1850 cows across an expansive, high-performing dairy operation while improving efficiency, mating outcomes and day-to-day decision making.
Fonterra has unveiled its annual results for the 2026 financial year, posting $27 billion in revenue and close to $20 billion returned to New Zealand farmer owners and unit holders.
The first major update to the Dairy Cattle Code of Welfare in more than a decade has been released, marking what DairyNZ describes as an important step in ensuring animal welfare standards continue to evolve alongside scientific evidence and on-farm realities.
Ravensdown shareholders have elected Jane Montgomery and Kate Acland to the Ravensdown Board for three-year terms, following a closely contested director election.
Federated Farmers says new legislation replacing the Resource Management Act will cut red tape, unlock investment and help grow New Zealand's export-led economy, after the Planning Bill and Natural Environment Bill passed their third reading in Parliament yesterday.
OPINION: It seems Canterbury processor Synlait is still in the doldrums.
OPINION: Get offside with New Zealand First leader Winston Peters at your own peril.